ACS 2019: The Patient Experience and Clinical Outcomes in Urologic Cancers: A SEER-CAHPS Study

San Francisco, California (  Charan S. Mohan, BS, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, wanted to understand the impact of the patient experience among oncologic patients. They used the SEER-CAHPS combined database to understand the relationship between the patient experience, as measured by patient-reported scores on the CAHPS survey, and clinical outcomes in patients with prostate and bladder cancer. They analyzed records of patients with a diagnosis of prostate or bladder cancer in the SEER PEDSF between the years 2001 to 2013 and who completed a CAHPS survey within 5 years of the first diagnosis with cancer. They conducted a multivariate analysis, controlling for sociodemographic characteristics and clinical stage, to evaluate the association between CAHPS score with the following clinical outcomes all within the first 2 years following survey administration: mortality, ED visits, inpatient admissions, and total healthcare expenditures.

A total of 4,870 patient files were included in the prostate cancer cohort and 1,169 for bladder cancer. On multivariate analysis controlling for sociodemographic factors and clinical stage, some elements of patient-reported experience with healthcare appeared to be negatively associated with mortality and/or resource utilization. Prostate cancer patients reporting better scores for overall care and their primary care physician appeared to have decreased overall costs but worse mortality. Bladder cancer patients reporting better scores for their specialist appeared to have worse mortality.

They concluded the patient-reported experience with healthcare does not appear to be positively associated with resource utilization or mortality for prostate or bladder cancer. Further work is warranted to better understand the relationship between patient experience and quality of care.

Presented by: Charan S. Mohan, BS, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina

Written by: Stephen B. Williams, MD, Medical Director for High Value Care; Chief of Urology, Associate Professor, Director of Urologic Oncology, Director Urologic Research, The University of Texas Medical Branch at Galveston, TX at the 2019 American College of Surgeons (ACS), #ACSCC19, October 27–31 in San Francisco, California